BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Almalki AH, Sadagah LF, Qureshi M, Maghrabi H, Algain A, Alsaeed A. Atypical hemolytic-uremic syndrome due to complement factor I mutation. World J Nephrol 2017; 6(6): 243-250 [PMID: 29226095 DOI: 10.5527/wjn.v6.i6.243]
URL: https://www.wjgnet.com/2307-8960/full/v6/i6/243.htm
Number Citing Articles
1
Yulia V. Lavrishcheva, Alexander A. Yakovenko, Dmitrii A. Kudlai. The experience of using the Russian biosimilar of the original drug eculizumab for the treatment of patients with atypical hemolytic-uremic syndromeTerapevticheskii arkhiv 2020; 92(6): 76 doi: 10.26442/00403660.2020.06.000649